Western Standard LLC’s Acceleron Pharma XLRN Stock Holding History

Western Standard LLC’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-84,990	Closed	-$14.6M	–	43
2021 Q3	$14.6M	Buy	84,990 +59,955	+239%	+$7.84M	8.32%	3
2021 Q2	$3.14M	Buy	+25,035	New	+$3.16M	1.85%	15

Western Standard LLC's XLRN Position: Q4 2021 in Review

Western Standard LLC sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 84,990 shares — an estimated $14.6M sold.

Western Standard LLC first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $14.6M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Western Standard LLC reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Western Standard LLC sold 84,990 Acceleron Pharma shares in Q4 2021, an estimated $14.6M.
Western Standard LLC first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
Western Standard LLC's Acceleron Pharma position peaked at $14.6M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Western Standard LLC's 13F filing for Q4 2021, filed 14 Feb 2022.